We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$33.8M
2
BNY
Bank of New York Mellon
BNY
+$16.4M
3
T icon
AT&T
T
+$9.63M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$7.05M
5
TWTR
Twitter, Inc.
TWTR
+$6.76M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
2151
Ocular Therapeutix
OCUL
$2.14B
$117K ﹤0.01%
+17,358
New +$119K
STGW icon
2152
Stagwell
STGW
$2.27B
$117K ﹤0.01%
25,380
– –
CLSD
2153
DELISTED
Clearside Biomedical
CLSD
$116K ﹤0.01%
724
– –
CULP icon
2154
Culp Inc
CULP
$43.7M
$115K ﹤0.01%
4,697
– –
DRRX
2155
DELISTED
DURECT Corp
DRRX
$115K ﹤0.01%
7,388
– –
BNED icon
2156
Barnes & Noble Education
BNED
$435M
$110K ﹤0.01%
+195
New +$130K
DMRC icon
2157
Digimarc Corp
DMRC
$172M
$106K ﹤0.01%
3,943
– –
EMCI
2158
DELISTED
EMC INS Group Inc
EMCI
$106K ﹤0.01%
3,800
– –
CIVI
2159
DELISTED
Civitas Solutions, Inc.
CIVI
$106K ﹤0.01%
6,456
– –
PVLA
2160
Palvella Therapeutics
PVLA
$2.22B
$105K ﹤0.01%
258
– –
AAIC
2161
DELISTED
Arlington Asset Investment Corp.
AAIC
$104K ﹤0.01%
10,056
– –
HYG icon
2162
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$102K ﹤0.01%
1,202
-3,160
-72% -$271K
PTE
2163
DELISTED
PolarityTE, Inc. Common Stock
PTE
$100K ﹤0.01%
+171
New +$102K
RMTI icon
2164
Rockwell Medical
RMTI
$27.9M
$93K ﹤0.01%
171
– –
JCAP
2165
DELISTED
Jernigan Capital, Inc.
JCAP
$93K ﹤0.01%
4,880
– –
AGEN
2166
Agenus
AGEN
$307M
– –
-970
Closed -$90K
APLS
2167
DELISTED
Apellis Pharmaceuticals
APLS
– –
-5,716
Closed -$126K
EFOR
2168
Everforth Inc
EFOR
$1.35B
– –
-22,539
Closed -$1.84M
ATEX icon
2169
Anterix
ATEX
$1.81B
– –
-3,369
Closed -$101K
BH icon
2170
Biglari Holdings Class B
BH
$1.2B
– –
-792
Closed -$216K
BHF icon
2171
Brighthouse Financial
BHF
$3.38B
– –
-28,835
Closed -$1.48M
BHR
2172
Braemar Hotels & Resorts
BHR
$138M
– –
-14,666
Closed -$141K
BKNG icon
2173
Booking.com
BKNG
$160B
– –
-366,925
Closed -$30.5M
CADE
2174
DELISTED
Cadence Bank
CADE
– –
-90,807
Closed -$2.89M
CLDX icon
2175
Celldex Therapeutics
CLDX
$3.48B
– –
-1,561
Closed -$55K
85 86
87
88 89

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.